Table 4.
Sleep burden by self-reported AD severity and in matched non-AD control cohort
| AD cohort N = 4208 |
Matched non-AD control cohort N = 4208 |
P valuea | |||
|---|---|---|---|---|---|
| Mild AD n = 2862 |
Moderate AD n = 1177 |
Severe AD n = 169 |
|||
| At least one sleep difficulty | 1418 (49.6) | 647 (55.0) | 105 (62.1) | 1636 (38.9) | < 0.0001 |
| Severity of sleep difficulties | |||||
| Mild | 758 (26.5) | 241 (20.5) | 30 (17.8) | 857 (20.4) | < 0.0001 |
| Moderate | 524 (18.3) | 294 (25.0) | 41 (24.3) | 607 (14.4) | |
| Severe | 136 (4.8) | 112 (9.5) | 34 (20.1) | 172 (4.1) | |
| Impact of sleep difficulties | |||||
| No impact | 151 (5.3) | 58 (4.9) | 11 (6.5) | 200 (4.8) | < 0.0001 |
| Little impact | 423 (14.8) | 145 (12.3) | 19 (11.2) | 482 (11.5) | |
| Mild impact | 376 (13.1) | 171 (14.5) | 18 (10.7) | 451 (10.7) | |
| Moderate impact | 349 (12.2) | 214 (18.2) | 38 (22.5) | 392 (9.3) | |
| Severe impact | 119 (4.2) | 59 (5.0) | 19 (11.2) | 111 (2.6) | |
AD atopic dermatitis
Data reported as n (%)
aAD cohort (mild, moderate, or severe) versus matched non-eczema control cohort